Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Healthcare Biotechnology

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Comment by wallpaper2on Jul 29, 2020 5:00pm

138 Views

Post# 31339998

RE:RE:RE:RE:RE:Y’all see this? ...

I read where your calculations said "every 5 million units sold translated into $15-$16 per share."
So 100 million would work out to 20x$15.50= $310 per share. Am I reading this wrong.
Are we now at $41/share on the sale of 100 million kits?

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features